BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26683928)

  • 1. Genomic Copy Number Variations Characterize the Prognosis of Both P16-Positive and P16-Negative Oropharyngeal Squamous Cell Carcinoma After Curative Resection.
    Rhie A; Park WS; Choi MK; Kim JH; Ryu J; Ryu CH; Kim JI; Jung YS
    Medicine (Baltimore); 2015 Dec; 94(50):e2187. PubMed ID: 26683928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
    Berdugo J; Rooper LM; Chiosea SI
    Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.
    Reimers N; Kasper HU; Weissenborn SJ; Stützer H; Preuss SF; Hoffmann TK; Speel EJ; Dienes HP; Pfister HJ; Guntinas-Lichius O; Klussmann JP
    Int J Cancer; 2007 Apr; 120(8):1731-8. PubMed ID: 17236202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
    van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
    Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
    Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
    Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
    Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
    Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
    Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV status of oropharyngeal cancer by combination HPV DNA/p16 testing: biological relevance of discordant results.
    Hong A; Jones D; Chatfield M; Lee CS; Zhang M; Clark J; Elliott M; Harnett G; Milross C; Rose B
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S450-8. PubMed ID: 23208131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
    Huang H; Zhang B; Chen W; Zou SM; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.
    Chen C; Zhang Y; Loomis MM; Upton MP; Lohavanichbutr P; Houck JR; Doody DR; Mendez E; Futran N; Schwartz SM; Wang P
    PLoS One; 2015; 10(8):e0135074. PubMed ID: 26247464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit of chemotherapy as part of treatment for HPV DNA-positive but p16-negative squamous cell carcinoma of the oropharynx.
    Junor E; Kerr G; Oniscu A; Campbell S; Kouzeli I; Gourley C; Cuschieri K
    Br J Cancer; 2012 Jan; 106(2):358-65. PubMed ID: 22146523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome.
    Näsman A; Andersson E; Marklund L; Tertipis N; Hammarstedt-Nordenvall L; Attner P; Nyberg T; Masucci GV; Munck-Wikland E; Ramqvist T; Dalianis T
    PLoS One; 2013; 8(10):e77025. PubMed ID: 24130830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.
    Fakhry C; Zhang Q; Nguyen-Tan PF; Rosenthal D; El-Naggar A; Garden AS; Soulieres D; Trotti A; Avizonis V; Ridge JA; Harris J; Le QT; Gillison M
    J Clin Oncol; 2014 Oct; 32(30):3365-73. PubMed ID: 24958820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.